2 results match your criteria: "St. Lukes Mid America Heart Institute[Affiliation]"
Site Variability in Cerebral Embolic Protection for Transcatheter Aortic Valve Implantation and Association With Outcomes.
Struct Heart
November 2023
Department of Cardiovascular Medicine, St Lukes Mid America Heart Institute, Kansas City, Missouri, USA.
Article Synopsis
- The study examines the use of cerebral embolic protection devices (CEPD) during transcatheter aortic valve implantation (TAVI) across US hospitals to understand their effectiveness in preventing strokes.
- Out of over 41,800 TAVI procedures analyzed, only 10.6% utilized CEPD, with 65.8% of hospitals not using these devices.
- Results indicated no significant differences in stroke or death rates between hospitals that used CEPD and those that did not, while costs were found to be lower in non-user hospitals.
A sex stratified outcome analysis from the OPEN-CTO registry.
Catheter Cardiovasc Interv
May 2019
St. Lukes Mid America Heart Institute, Kansas City, Missouri.
Introduction: Women have been under-represented in trials. Due to the dearth of information about CTO-PCI in women and discordance of previous results, sex differences in outcomes in the OPEN-CTO Trial were investigated.
Methods: OPEN-CTO is an investigator-initiated, multicenter, prospective observational registry of consecutive CTO patients undergoing PCI at 12 U.